Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

8.9K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bimetallic Steels: A Structured Review of Fabrication Routes, Material Properties, and Component Performance.

Materials (Basel, Switzerland)·2026
Same author

Qishen paste improves cardiac conduction in heart failure by regulating cardiac resident macrophage Connexin43.

Journal of ethnopharmacology·2026
Same author

Systemic inflammation response index as an independent predictor of unfavorable prognosis and its application in risk stratification in patients with aneurysmal subarachnoid hemorrhage.

Frontiers in neuroscience·2026
Same author

Mendelian Randomization Analysis of the Relationship between Neurotransmitter-related Genes and Cancer: Insights from Multi-omics Data.

Current topics in medicinal chemistry·2026
Same author

Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels.

ACS applied bio materials·2026
Same author

INTELCAPE: A Deep Learning-Powered System for Automated, High-Accuracy Crohn's Disease Diagnosis via Capsule Endoscopy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same journal

Challenges and Perspectives in ncRNA Research.

Experientia supplementum (2012)·2026
Same journal

Bioinformatics Approaches in Noncoding RNAs Research.

Experientia supplementum (2012)·2026
Same journal

Noncoding RNA in Clinical Trials: Diagnostic and Therapeutical Prospects.

Experientia supplementum (2012)·2026
Same journal

MitomiRs as Key Players in Metabolic Reprogramming of Blood Cell Development.

Experientia supplementum (2012)·2026
Same journal

Noncoding RNAs in Metabolic Reprogramming of Breast Cancer: Dietary Opportunities and Translational Implications.

Experientia supplementum (2012)·2026
Same journal

Silhouette of Probiotics in the Regulation of miRNAs and lncRNAs in Carcinogenesis and Metastasis: Is It a Silver Lining or a Cross to Bear.

Experientia supplementum (2012)·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

AMPK and Cancer.

Zhiyu Wang1, Neng Wang2, Pengxi Liu3

  • 1Department of Mammary Disease, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Collage of Guangzhou University of Chinese Medicine, Guangzhou, China. wangzhiyu976@126.com.

Experientia Supplementum (2012)
|November 5, 2016
PubMed
Summary
This summary is machine-generated.

AMP-activated protein kinase (AMPK) acts as a stress-response molecule, inhibiting cancer growth but also promoting drug resistance. Targeting AMPK offers a new strategy for cancer prevention and treatment.

Keywords:
AMPKCancer drug resistanceCancer prevetionCarcinogenesisStress-response

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890
Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K

Related Experiment Videos

Last Updated: Mar 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890
Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Stress Response

Background:

  • AMP-activated protein kinase (AMPK) is a key cellular energy sensor.
  • Its role in cancer is complex, involving both tumor suppression and promotion of drug resistance.

Purpose of the Study:

  • To elucidate the dual role of AMPK in carcinogenesis and cancer drug resistance.
  • To explore AMPK as a therapeutic target for cancer treatment.

Main Methods:

  • Review of existing literature on AMPK signaling pathways.
  • Analysis of AMPK's interaction with tumor suppressors (LKB1, P53) and oncogenic pathways (mTOR, Akt).
  • Examination of AMPK's involvement in chemoresistance mechanisms (ABCG2, autophagy, cancer stem cells).

Main Results:

  • AMPK activation, linked to LKB1 and P53, inhibits cell growth and arrests the cell cycle.
  • Conversely, AMPK contributes to cancer drug resistance by influencing ABCG2 expression, autophagy, and cancer stem cell enrichment.
  • AMPK's complex role highlights its significance in cancer progression and treatment failure.

Conclusions:

  • AMPK exhibits a dichotomous role in cancer, acting as both a tumor suppressor and a facilitator of drug resistance.
  • Targeting AMPK presents a promising novel strategy for cancer prevention and therapeutic intervention.
  • Further research into AMPK modulation is crucial for effective cancer treatment development.